Maximize your thought leadership

Creative Biolabs Launches LipoDrive™ Platform to Streamline Liposome-Based Drug Delivery Development

TL;DR

Creative Biolabs' LipoDrive™ platform offers a competitive edge by accelerating lipid-based drug development with high-performance, flexible solutions that save time and enhance accuracy.

The LipoDrive™ platform utilizes microfluidic technology, custom lipid synthesis, and advanced analytics for efficient liposome formulation, ensuring repeatable, homogeneous batches and precise drug delivery.

By advancing liposome technology, Creative Biolabs contributes to precision medicine, improving drug delivery systems for better treatment outcomes and enhancing global healthcare solutions.

Discover how Creative Biolabs is revolutionizing drug delivery with its LipoDrive™ platform, blending innovation in microfluidics and lipid synthesis for groundbreaking therapeutic applications.

Found this article helpful?

Share it with your network and spread the knowledge!

Creative Biolabs Launches LipoDrive™ Platform to Streamline Liposome-Based Drug Delivery Development

Creative Biolabs has unveiled its LipoDrive™ platform, a comprehensive solution designed to streamline the development and manufacturing of liposome-based drug delivery systems. This innovation comes at a time when the biopharmaceutical industry seeks faster, more stable formulations for nucleic acids, peptides, and small molecules. The platform's integration of microfluidic technology, custom lipid synthesis, and advanced analytical equipment promises to enhance formulation accuracy and reduce development time.

The LipoDrive™ platform offers several key benefits, including the ability to synthesize lipids tailored to specific delivery goals, produce homogeneous batches of liposomes, and encapsulate a diverse range of payloads. Additionally, it supports surface functionalization for targeted delivery and employs advanced characterization techniques to ensure the structure and function of liposomes meet required standards. These features make the platform versatile for applications such as mRNA vaccine manufacturing, CAR-T delivery vectors, and cosmeceutical formulations.

Creative Biolabs also provides liposomal manufacturing services that span from pilot-scale feasibility studies to commercial-scale production. These services are characterized by high-yield, reproducible production processes, adherence to international quality control standards, and the encapsulation of active bioingredients to improve bioavailability. The company's manufacturing facilities are designed to be cost-efficient and regulatory compliant, ensuring the production of high-quality liposomal products for various applications.

According to a company scientist, the combination of the LipoDrive™ platform with robust manufacturing capabilities positions Creative Biolabs as a strategic collaborator in lipid-based innovation. This end-to-end approach is expected to accelerate the transition from conceptual research to market-ready products, addressing the global demand for advanced drug delivery systems. For more information, visit https://www.creative-biolabs.com/lipid-based-delivery/.

Curated from 24-7 Press Release

blockchain registration record for this content
Burstable Health Team

Burstable Health Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.